Earnings · China A-shares
Zhejiang Yatai Pharmaceutical Co., Ltd. Class A (002370) earnings
Zhejiang Yatai Pharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-25: net profit -114.66% year on year, +73.17% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -6.07% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-25
- Period end
- 2026-09-30
- Net profit YoY
- -114.66%
- Excl. one-offs YoY
- +73.17%
- Net profit QoQ
- -742.04%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -2.30% | — |
| 3 days | -6.07% | — |
| 7 days | -8.16% | — |
| 14 days | -3.14% | — |
Report history
Over the last 8 reports, net profit grew year on year in 5 of them. The stock rose in the 3 trading days after 2 of 7 reports (average +0.64%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-26 | -¥14.25M | -114.66% | +73.17% | -4.35% | -0.02 | -1.28% | -6.07% | — | — |
| 2026 interim report | 2026-08-26 | -¥435.47K | -100.41% | +102.86% | +3.58% | 0.00 | -0.04% | -0.89% | -10.00% | -3.01% |
| 2026 Q1 report | 2026-04-25 | -¥2.59M | +66.84% | +42.24% | -7.71% | 0.00 | -0.23% | -4.89% | -23.28% | -22.97% |
| 2025 annual report | 2026-04-25 | ¥96.31M | +181.27% | — | -20.25% | 0.13 | 9.21% | -4.89% | -23.28% | -22.97% |
| 2025 Q3 report | 2025-10-29 | ¥97.20M | +2909.49% | — | -25.59% | 0.13 | 9.21% | +11.38% | +10.67% | +14.15% |
| 2025 interim report | 2025-08-30 | ¥105.18M | +1820.97% | — | -31.48% | 0.14 | 10.01% | +8.58% | +11.70% | +10.86% |
| 2025 Q1 report | 2025-04-30 | -¥7.80M | -160.25% | — | -42.73% | -0.01 | -0.79% | -0.93% | +19.44% | +16.27% |
| 2024 annual report | 2025-04-25 | ¥34.24M | +388.29% | +59.20% | -3.68% | 0.05 | 5.23% | -2.70% | +17.42% | +14.17% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.